Risk of hepatitis B reactivation following treatment with baricitinib or tocilizumab for COVID-19

Foo, H.; Phan, F.; Bagatella, M.; Acharya, P.; Petrovski, I.; Nagendra, V.; Levy, M.; Prakoso, E.

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Risk of hepatitis B reactivation following treatment with baricitinib or tocilizumab for COVID-19

Foo, H.; Phan, F.; Bagatella, M.; Acharya, P.; Petrovski, I.; Nagendra, V.; Levy, M.; Prakoso, E..

Journal of Gastroenterology and Hepatology ; 37:71-72, 2022.

Article in English | Web of Science | ID: covidwho-2030729

Search on Google

Print

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Prognostic study Language: English Journal: Journal of Gastroenterology and Hepatology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Print

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Prognostic study Language: English Journal: Journal of Gastroenterology and Hepatology Year: 2022 Document Type: Article